ALC:NYE-Alcon AG (USD)

COMMON STOCK | Medical Instruments & Supplies |

Last Closing

USD 96.8

Change

+5.48 (+6.00)%

Market Cap

USD 46.01B

Volume

3.59M

Analyst Target

USD 65.36
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-03-27 )

Largest Industry Peers for Medical Instruments & Supplies

Symbol Name Price(Change) Market Cap
BDX Becton Dickinson and Company

N/A

USD 65.91B
RMD ResMed Inc

N/A

USD 34.14B
BAX Baxter International Inc

N/A

USD 18.71B
AVTR Avantor Inc

N/A

USD 11.92B
ATR AptarGroup Inc

N/A

USD 10.16B
TFX Teleflex Incorporated

N/A

USD 6.39B
STVN Stevanato Group SpA

N/A

USD 5.88B
BLCO Bausch + Lomb Corp

N/A

USD 5.64B
WRBY Warby Parker Inc

N/A

USD 2.55B
INFU InfuSystems Holdings Inc

N/A

USD 0.13B

ETFs Containing ALC

CHSR:XETRA UBS(Lux)Fund Solutions .. 5.08 % 0.00 %

N/A

USD 0.17B
CHSRI:SW UBS ETF (CH) - MSCI Switz.. 5.01 % 0.00 %

N/A

N/A
CHSRIA:SW UBS ETF (CH) MSCI Switzer.. 5.01 % 0.00 %

N/A

N/A
CHSRII:SW UBS(Lux)Fund Solutions .. 4.98 % 0.00 %

N/A

N/A
SLICHA:SW UBS ETF (CH) – SLI® (C.. 4.34 % 0.00 %

N/A

USD 32,912.73B
XSLI:SW Xtrackers SLI UCITS ETF 1.. 4.34 % 0.00 %

N/A

USD 0.31B
CSSLI:SW iShares SLI® ETF (CH) 4.34 % 0.00 %

N/A

USD 0.67B
SMIEX:SW iShares SLI UCITS ETF (DE.. 4.32 % 0.00 %

N/A

USD 5,933.96B
CBCH30:SW 3.78 % 0.00 %

N/A

N/A
XSMI:XETRA Xtrackers Switzerland UCI.. 3.15 % 0.00 %

N/A

N/A
ESRU:LSE Amundi Index Solutions - .. 3.12 % 0.00 %

N/A

N/A
ACU7:XETRA Amundi Index Solutions - .. 3.11 % 0.00 %

N/A

USD 0.13B
ESDU:LSE Amundi Index Solutions - .. 3.09 % 0.00 %

N/A

N/A
XSMC:SW Xtrackers Switzerland UCI.. 3.05 % 0.00 %

N/A

USD 0.51B
XSMI:SW Xtrackers Switzerland UCI.. 3.05 % 0.00 %

N/A

USD 1.36B
CSSMI:SW iShares SMI® ETF (CH) 3.04 % 0.00 %

N/A

USD 2.16B
SMICHA:SW UBS ETF (CH) – SMI® (C.. 3.04 % 0.00 %

N/A

USD 17,142.72B
CHEUR:SW UBS(Lux)Fund Solutions .. 2.79 % 0.00 %

N/A

N/A
CHEURD:SW UBS(Lux)Fund Solutions .. 2.79 % 0.00 %

N/A

N/A
CHUSD:SW UBS(Lux)Fund Solutions .. 2.79 % 0.00 %

N/A

N/A
CHUSDD:SW UBS(Lux)Fund Solutions .. 2.79 % 0.00 %

N/A

N/A
SWEUAH:SW UBS ETF (CH) – MSCI Swi.. 2.70 % 0.00 %

N/A

USD 226,274.20B
SWUSAH:SW UBS ETF (CH) – MSCI Swi.. 2.70 % 0.00 %

N/A

USD 226,274.21B
SWICHA:SW UBS ETF (CH) – MSCI Swi.. 2.70 % 0.00 %

N/A

USD 226,274.25B
SW2CHA:SW UBS(Lux)Fund Solutions .. 2.68 % 0.00 %

N/A

USD 0.49B
SW2CHB:SW UBS(Lux)Fund Solutions .. 2.68 % 0.00 %

N/A

USD 1.76B
SW2UKD:SW UBS(Lux)Fund Solutions .. 2.68 % 0.00 %

N/A

USD 0.04B
S2HGBD:SW UBS(Lux)Fund Solutions .. 2.68 % 0.00 %

N/A

USD 0.07B
S2HGBA:SW UBS(Lux)Fund Solutions .. 2.68 % 0.00 %

N/A

USD 8.29M
STWX:SW SPDR® MSCI Europe Health.. 2.62 % 0.00 %

N/A

USD 0.66B
ESRG:LSE Amundi Index Solutions - .. 2.60 % 0.00 %

N/A

USD 2.03B
ESDG:LSE Amundi Index Solutions - .. 2.60 % 0.00 %

N/A

USD 0.19B
SXDPEX:SW iShares STOXX Europe 600 .. 2.54 % 0.00 %

N/A

USD 0.44B
HEAE:LSE SPDR® MSCI Europe Health.. 2.50 % 0.00 %

N/A

N/A
SPICHA:SW UBS ETF (CH) – SPI® (C.. 2.46 % 0.00 %

N/A

USD 131,872.43B
ASRP:XETRA BNP Paribas Easy ECPI Glo.. 2.26 % 0.00 %

N/A

N/A
MTUSD:PA BNP Paribas Easy ECPI Glo.. 2.16 % 0.00 %

N/A

N/A
MEDTE:PA BNP Paribas Easy ECPI Glo.. 2.10 % 0.00 %

N/A

N/A
VLED:SW BNP Paribas Easy ESG Equi.. 2.07 % 0.00 %

N/A

USD 5.68M
EWL iShares MSCI Switzerland .. 0.00 % 0.47 %

N/A

N/A
LNGR 0.00 % 0.50 %

N/A

N/A
RNDM 0.00 % 0.65 %

N/A

N/A
FLSW Franklin FTSE Switzerland.. 0.00 % 0.09 %

N/A

USD 0.06B
HLTH:LSE SPDR® MSCI Europe Health.. 0.00 % 0.00 %

N/A

N/A
XSDR:LSE Xtrackers MSCI Europe Hea.. 0.00 % 0.00 %

N/A

USD 0.23B
UC93:LSE UBS MSCI Switzerland 20/3.. 0.00 % 0.00 %

N/A

USD 8.21M
UC94:LSE UBS(Lux)Fund Solutions .. 0.00 % 0.00 %

N/A

USD 0.07B
EUSRI:PA Amundi Index Solutions - .. 0.00 % 0.00 %

N/A

USD 2.00B
EVOE:PA BNP Paribas Easy ESG Equi.. 0.00 % 0.00 %

N/A

USD 0.06B
STW:PA SPDR® MSCI Europe Health.. 0.00 % 0.00 %

N/A

USD 0.72B
VLED:PA BNP Paribas Easy ESG Equi.. 0.00 % 0.00 %

N/A

USD 5.76M
C030:F Lyxor DJ Switzerland Tita.. 0.00 % 0.00 %

N/A

USD 0.01B
DBXS:F 0.00 % 0.00 %

N/A

N/A
DXS0:F Xtrackers - SLI UCITS ETF 0.00 % 0.00 %

N/A

N/A
DXSE:F Xtrackers Stoxx Europe 60.. 0.00 % 0.00 %

N/A

N/A
EL4X:F Deka DAXplus Maximum Divi.. 0.00 % 0.00 %

N/A

N/A
EXI1:F iShares SLI UCITS ETF (DE.. 0.00 % 0.00 %

N/A

N/A
EXV4:F 0.00 % 0.00 %

N/A

N/A
EXV5:F 0.00 % 0.00 %

N/A

N/A
MIVB:F Amundi Index Solutions - .. 0.00 % 0.00 %

N/A

N/A
SPYH:F SSgA SPDR ETFs Europe II .. 0.00 % 0.00 %

N/A

N/A
VLED:F BNP Paribas Easy - Equity.. 0.00 % 0.00 %

N/A

USD 0.07B
VLEU:F BNP Paribas Easy - Equity.. 0.00 % 0.00 %

N/A

USD 0.05B
C030:XETRA Amundi Index Solutions - .. 0.00 % 0.00 %

N/A

USD 0.13B
DBXS:XETRA Xtrackers - Switzerland U.. 0.00 % 0.00 %

N/A

USD 1.34B
DXS0:XETRA Xtrackers SLI UCITS ETF 1.. 0.00 % 0.00 %

N/A

USD 0.26B
DXSE:XETRA Xtrackers - Stoxx Europe .. 0.00 % 0.00 %

N/A

USD 0.14B
EXI1:XETRA iShares SLI UCITS ETF (DE.. 0.00 % 0.00 %

N/A

USD 0.37B
EXV4:XETRA iShares STOXX Europe 600 .. 0.00 % 0.00 %

N/A

USD 0.70B
MIVB:XETRA Amundi Index Solutions - .. 0.00 % 0.00 %

N/A

N/A
SPYH:XETRA SPDR® MSCI Europe Health.. 0.00 % 0.00 %

N/A

N/A
1391:TSE 0.00 % 0.00 %

N/A

N/A
CHSPI:SW iShares Core SPI® ETF (C.. 0.00 % 0.00 %

N/A

USD 4.06B
CEFA Global X S&P Catholic Val.. 0.00 % 0.00 %

N/A

USD 0.02B
ESIH:LSE iShares MSCI Europe Healt.. 0.00 % 0.00 %

N/A

USD 0.83B
ESIH:F Ishares VI PLC - Ishares .. 0.00 % 0.00 %

N/A

N/A
ESIH:XETRA iShares MSCI Europe Healt.. 0.00 % 0.00 %

N/A

N/A
CHDIV:SW UBS ETF (CH) - MSCI Switz.. 0.00 % 0.00 %

N/A

USD 1,244,681.59B

Market Performance

  Market Performance vs. Industry/Classification (Medical Instruments & Supplies) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 14.03% 94% A 92% A
Dividend Return N/A N/A N/A N/A N/A
Total Return 14.03% 94% A 92% A
Trailing 12 Months  
Capital Gain 16.22% 89% A- 85% B
Dividend Return 0.32% 33% F 4% F
Total Return 16.54% 89% A- 82% B
Trailing 5 Years  
Capital Gain 106.26% 93% A 70% C-
Dividend Return N/A N/A N/A N/A N/A
Total Return 106.26% 93% A 63% D
Average Annual (5 Year Horizon)  
Capital Gain 11.22% 84% B 68% D+
Dividend Return 11.49% 84% B 63% D
Total Return 0.27% 30% F 8% B-
Risk Return Profile  
Volatility (Standard Deviation) 16.94% 89% A- 61% D-
Risk Adjusted Return 67.84% 100% F 79% B-
Market Capitalization 46.01B 93% A 95% A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

Low debt

The company is less leveraged than its peers ,, and is among the top quartile, which makes it more flexible. However, do check the news and look at its sector. Sometimes this is low because the company is not growing and has no growth potential.

Low volatility

The stock’s annual returns have been stable and consistent compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile. Although stability is good, also keep in mind it can limit returns.

High market capitalization

This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.

Positive cash flow

The company had positive total cash flow in the most recent four quarters.

Positive free cash flow

The company had positive total free cash flow in the most recent four quarters.

Superior Earnings Growth

This stock has shown top quartile earnings growth in the previous 5 years compared to its sector.

What to not like:
Poor return on assets

The company management has delivered below median return on assets in the most recent 4 quarters compared to its peers.

Poor capital utilization

The company management has delivered below median return on invested capital in the most recent 4 quarters compared to its peers.

Overpriced on cashflow basis

The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.

Overpriced on free cash flow basis

The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Low Dividend Growth

This stock has shown below median dividend growth in the previous 5 years compared to its sector.